STAT3 and hepatocellular carcinoma: Yang et al. revealed that miR-122 could decrease cell proliferation and promote apoptosis of HCC cells via targeting c-MET and inhibiting its downstream ERK1/2, STAT3, and Akt/mTOR signaling [93].